SaMD Registration in the EU || Tacit MedTek

AI-SaMD/Digital Health Services

Quick Snapshot

Service – AI-SaMD Registration in the European Union (EU)
Who can apply – Software Developers, Medical Device Manufacturers, Digital Health Companies, and EU or Non-EU Manufacturers
Timeline – Depends on MDR classification, conformity assessment requirements, and documentation readiness
Deliverables – Regulatory Applicability Assessment, MDR Classification Assessment, Technical Documentation Review, Clinical Evaluation Support, CE Marking Support, and Post-Market Compliance Support.
Purpose – Support AI-SaMD manufacturers in achieving compliance with EU MDR requirements, preparing technical documentation, and obtaining CE marking for access to the European market.

What is AI-SaMD Registration?

Artificial Intelligence Software as a Medical Device (AI-SaMD) refers to software that utilizes Artificial Intelligence (AI) or Machine Learning (ML) technologies to perform medical functions through software-based processes. These solutions may support diagnosis, disease prediction, clinical decision-making, patient monitoring, treatment planning, medical image analysis, and other healthcare applications.

In the European Union, AI-SaMD products are regulated under the Medical Device Regulation (EU MDR 2017/745). Software that meets the definition of a medical device must comply with applicable regulatory requirements before it can be placed on the EU market and bear the CE marking.

Compliance with EU MDR requirements helps demonstrate that AI-enabled medical software is safe, performs as intended, and maintains an acceptable benefit-risk profile throughout its lifecycle. It also facilitates access to the European market while enhancing confidence among healthcare professionals, patients, and stakeholders.

When Do You Need AI-SaMD Registration?

Support for organizations assessing AI-enabled software under the EU MDR, determining classification, preparing conformity assessment documentation, and managing ongoing regulatory obligations.

When Do You Need AI-SaMD Registration?

AI-powered diagnostic software
Clinical decision-support systems (CDSS)
Medical image analysis and interpretation tools
Disease prediction and risk-stratification software
Remote patient-monitoring applications
AI-assisted treatment-planning solutions
Digital therapeutics using AI technologies
Pathology and radiology AI applications
Predictive healthcare analytics platforms
Software used for disease management and patient care

Key Challenges

Determining whether the software qualifies as a medical device under the EU MDR
Applying MDR Rule 11 for software classification
Identifying the appropriate conformity-assessment pathway
Demonstrating clinical performance and clinical benefit
Managing AI-model updates and software modifications
Establishing robust risk-management processes
Addressing cybersecurity and data-protection requirements
Preparing comprehensive technical documentation
Meeting post-market surveillance obligations
Coordinating with Notified Bodies where applicable

Our Approach and What You Will Get

Comprehensive support for organizations preparing AI-enabled medical software for EU MDR compliance, CE marking, and ongoing post-market obligations.

Our Approach

Classification and regulatory strategy
Gap assessment and compliance planning
Technical documentation review
Quality and compliance assessment
CE marking support
Post-market compliance support

What You Will Get (Deliverables)

Regulatory applicability assessment
MDR classification assessment
Regulatory strategy and compliance roadmap
Documentation gap analysis
Technical documentation review
Clinical evaluation support
Risk-management assessment
Cybersecurity-compliance guidance
Quality-management-system support
CE-marking preparation support
Regulatory-query assistance
Post-market compliance recommendations

Why Choose Tacit Medtek and Case Example

Practical, risk-based support for AI-enabled healthcare software seeking EU MDR compliance, CE marking readiness, and sustainable market access.

Why Choose Tacit Medtek?

Expertise in EU MDR requirements for medical software
Experience supporting AI-enabled healthcare technologies
Strong understanding of software classification under MDR Rule 11
Structured and risk-based compliance strategies
Comprehensive technical and regulatory documentation support
End-to-end guidance throughout the conformity-assessment process
Support for CE marking and post-market compliance activities
Focus on efficient and sustainable market access

Case Example

Challenge: A digital health company developed an AI-powered software platform to help healthcare professionals analyse patient data and identify potential clinical risks. The organization needed guidance on software classification, clinical-evaluation requirements, and CE-marking obligations under the EU MDR.
Our Approach: Tacit Medtek performed a regulatory assessment, determined the applicable software classification, reviewed technical documentation, assessed clinical evidence, and developed a tailored compliance strategy to support EU market access.
Outcome: The client established a clear regulatory pathway, strengthened its technical documentation, and successfully progressed toward EU MDR compliance and CE-marking readiness.

FAQ

Frequently Asked Questions

How is AI-SaMD classified in the European Union?

Software is classified according to the requirements of EU MDR, including MDR Rule 11, which specifically addresses software intended to provide information for clinical decision-making.

Does every AI healthcare application require CE marking?

No. Software intended solely for administrative, lifestyle, wellness, or non-medical purposes may not fall within the scope of EU MDR.

What is MDR Rule 11?

MDR Rule 11 is the classification rule used to determine the risk class of medical software based on its intended purpose and the significance of the information it provides.

Is a Clinical Evaluation required for AI-SaMD?

Yes. Clinical Evaluation is generally required to demonstrate the safety, performance, and clinical benefit of software regulated under EU MDR.

Can software updates affect EU MDR compliance?

Yes. Significant modifications to software functionality, intended use, or performance may require additional regulatory assessment and documentation updates.

Are cybersecurity requirements applicable to AI-SaMD?

Yes. Cybersecurity measures should be implemented to protect software integrity, patient information, and overall device performance throughout the lifecycle.

Get In Touch

Enquire Now

Send Enquiry

Fill in the form and our team will get back to you shortly.

Full Name

Phone

Email Address

Company Name

Subject

Type your Message...

Your information is secure and will never be shared.

Need Help?

Reach our regulatory experts directly.

+91 9409299368 Call Us

contact@tacitmedtek.com Email Us

bd@tacitmedtek.com Email Us